All News

FDA is seeking to learn how these Wallcur products, which are not sterile and should not be injected in humans or animals, entered the supply chain.

Topical treatment with vitamin D analogs and corticosteroids is the mainstay of first-line therapy for patients with localized psoriasis.

A group representing the nation’s governors has endorsed provider status for pharmacists as a way to improve medical outcomes and lower healthcare costs.

William Carey University in Mississippi recently received a $1 million donation to help fund a new pharmacy school set to open in about three years.

Calvin H. Knowlton, BS Pharm, MDiv, PhD, has been named this year’s Remington Honor Medal award winner and will be recognized next month at the American Pharmacists Association (APhA) annual meeting and exposition in San Diego.

An administrative hearing for a fired pharmacist has provided an eye-opening look into the workloads and the lack of accuracy standards for pharmacists working at Veterans Administration facilities in New Jersey.

For some pharmacists, leaving behind corporate constraints can be the start of something big.

Which comes first, diabetes or depression? While the connection is recognized, the answer is not yet certain.

Agency will use guidance in 2015 to address “key policy issues.”

In a world where insurance plans now fight for Star Ratings, why do we have a system that obstructs patients' efforts to obtain routine maintenance medications?

A Danish study of 150,900 patients found that the risk of serious bleeding doubled when patients were treated with NSAIDs.

Pharmacists face changes as the profession continues to redefine itself, but for most, the money's still good.

New OTC products offer several approaches to symptom relief.

Blister packs, close follow-up, and tight pharmacy planning are features of the new model.

What is it like to care for patients with Ebola? Clinical pharmacists share what they’ve learned.

What should pharmacies do to keep patient data and credit- and debit-card information secure? Start with these steps.

New drugs, new generics, new OTC

Let this be the year you do something for the cause.

Letters, e-mails, posts, and comments from readers of Drug Topics

That’s the assertion a Philadelphia-area pharmacist is making in a federal class action suit filed recently at the U.S. District Court for the Eastern District of Pennsylvania.

The factor Xa inhibitor edoxaban (Savaysa, Daiichi Sankyo) has been approved by FDA to lower the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), according to a January 8 announcement.

Prosecutors seized $18 million from accounts linked to the owners of the defunct New England Compounding Center, whose tainted products led to the 2012 meningitis outbreak that killed at least 64 people and sickened about 750.

Gloria E. Meredith was recently named founding dean of Binghamton University’s School of Pharmacy and Pharmaceutical Sciences in New York.

Looking back, what do you think was missing from your pharmacy education? And what should a 21st century curriculum include?

The U.S. Centers for Disease Control and Prevention and the American Pharmacists Association Foundation recently announced a partnership intended to integrate pharmacy into public health efforts to manage hypertension.

As her first major initiative, State Attorney General-Elect Maura Healey plans to create a taskforce to combat Massachusetts’ heroin and prescription drug crisis.

A pharmacy-led prior authorization service can generate additional hospital revenues through increased reimbursements and decreased write-offs, according to a case study to be published in the American Journal of Health-System Pharmacy.

Several state agencies here are combining resources to create strategies to prevent deaths and injuries from prescription-painkiller overdoses.

In an effort to curb prescription drug overdoses and short circuit pill-mills, Florida banned physician dispensing of strong opioids back in 2011.